GreenHy2 Ltd
(ASX:H2G) Share Price and News

Introduction to GreenHy2 (ASX:H2G)

GreenHy2 (ASX:H2G) is a provider of Solid-State Hydrogen Storage (SSHS) batteries. The technology leverages metal hydrides for hydrogen storage, storing the hydrogen molecules directly in a ferrous titanium lattice.

It is the only provider of this kind of technology resolving the issue of energy storage in a way that is environmentally-friendly (by not relying on fossil-fuel-backed diesel generators) and safe.

The eight key benefits are: Environmental sustainability, exceptional density, ability to operate at an extremely low pressure, an extended lifespan and reliability, the ability to store power indefinitely, reduced safety concerns, versatility and uniqueness.

GreenHy2's History

The company was incepted in 2011 by Charlie Bontempo. It was formerly known as Tempo Australia, only changing its name in 2022. The technology owned by the company was developed in Germany with GKN. H2G and GKN have the exclusive right to integrate, assembly and supply the equipment in Australia and New Zealand, as well as the right to act on a non-exclusive basis throughout Southeast Asia on a project-by-project basis subject to GKN's approval.

Future Outlook of GreenHy2

GreenHy2 is at an early stage but has a handful of key partnerships with industry players. In particular, it has run a 12-month trial with Essential Energy to use its hydrogen-powered batteries to power a heritage accommodation cottage on the NSW North Coast.

Is GreenHy2 Ltd (ASX:H2G) a Good Stock to Buy?

Investing in GreenHy2 presents a futuristic opportunity, albeit with risks typical of an early-stage company in an early-stage sector like Hydrogen. Overall, there's too much risk for most investors (particularly retail investors) to consider it.

Our Stock Analysis

Prescient Therapeutics

Prescient Therapeutics (ASX:PTX): About to take the plunge into a Phase 2 trial against T-Cell Lymphoma

There’s plenty of ASX oncology biotechs conducting clinical trials, but Prescient Therapeutics (ASX:PTX) is one of the closest to commercialisation.…

annual report of an ASX company

5 crucial things to look for in the annual report of an ASX company that may give you an advantage over other investors

5 crucial things to look out for in the annual report of an ASX company! The ASX reporting season is…

Humm Group

Humm Group (ASX:HUM): Its no Big 4 Bank, but has defied the market in 2024

Humm Group (ASX:HUM) has not had the year you might expect to a financier that is not either a Big…

ASX stocks at 12 month highs

Here are 5 ASX stocks at 12 month highs, and whether it is time to buy

Here are 5 ASX stocks at 12 month highs!   Humm Group (ASX:HUM) Humm has been through a difficult few…

Percheron Therapeutics

Percheron Therapeutics (ASX:PER): Releasing Phase II data by the end of CY24, and successful data could lead to a major re-rate

It has been less then a year since Antisense Therapeutics changed its name to Percheron Therapeutics (ASX:PER). It is common…

statutory results

Underlying v Statutory results? There’s a big difference between the 2 – here’s how to tell

When companies report results, you’ll hear underlying and statutory results. What is the difference between the two and how big…

Frequently Asked Questions

GreenHy2 specializes in developing Solid State Hydrogen Storage Batteries integrated with 100% renewable energy generation.